Filing Flows

Filing Flows › Comparisons › SNN vs EW

Smith & Nephew vs Edwards Lifesciences: SNN and EW compared

Smith & Nephew is the larger company: $3.1B of revenue in its latest quarter (H1 2026) against $1.7B for Edwards Lifesciences (Q3 2026). Edwards Lifesciences is growing faster (+10% against +5% a year earlier). Edwards Lifesciences is more profitable, with an operating margin of 17.4% against 14.5%.

Smith & Nephew vs Edwards Lifesciences, latest quarterSmith & Nephew vs Edwards Lifesciences, latest quarterSmith & Nephew (SNN)Edwards Lifesciences (EW)Revenue$3.1B$1.7BRevenue growth, Y/Y+5%+10%Gross margin70.9%78.5%Operating margin14.5%17.4%Net margin9.8%17.9%

Where the money goes: SNN and EW

Smith & Nephew (SNN) · H1 2026

Smith & Nephew, H1 2026: revenue $3.1B (+5% year over year), operating margin 14.5%, net earnings $303M, operating cash flow $450M. The chart follows the revenue to costs, profit and cash.

Edwards Lifesciences (EW) · Q3 2026

Edwards Lifesciences, Q3 2026: revenue $1.7B (+10% year over year), operating margin 17.4%, net earnings $308M, operating cash flow $570M. The chart follows the revenue to costs, profit and cash.

Edwards Lifesciences revenue by segment, Q3 2026Edwards Lifesciences revenue by segment, Q3 2026Transcatheter Aortic Valve Replac…$1.2BSurgical$264MTranscatheter Mitral and Tricuspi…$210M
Smith & Nephew (SNN)Edwards Lifesciences (EW)
Latest quarterH1 2026Q3 2026
Revenue$3.1B$1.7B
Revenue growth, Y/Y+5%+10%
Gross margin70.9%78.5%
Operating margin14.5%17.4%
Net earnings$303M$308M
Net margin9.8%17.9%
Operating cash flow$450M$570M
Free cash flow—$507M
Market value—$58.6B
P/E—57.3×
Analysts’ mean target—$111.64

Where the revenue comes from

Edwards Lifesciences

Questions

Which is bigger, Smith & Nephew or Edwards Lifesciences?

Smith & Nephew is the larger company: $3.1B of revenue in its latest quarter (H1 2026) against $1.7B for Edwards Lifesciences (Q3 2026).

Is Smith & Nephew or Edwards Lifesciences growing faster?

Edwards Lifesciences is growing faster (+10% against +5% a year earlier).

Which is more profitable, Smith & Nephew or Edwards Lifesciences?

Edwards Lifesciences is more profitable, with an operating margin of 17.4% against 14.5%.

More: Smith & Nephew earnings · how Smith & Nephew makes money · Edwards Lifesciences earnings · how Edwards Lifesciences makes money

From the companies' latest 10-Q, 10-K or earnings release (6-K filed Aug 14, 2026; 10-Q filed Nov 4, 2026). Fiscal quarters can end on different dates. Not investment advice.